Immix Biopharma, Inc. IMMX Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable
Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s share-based payment arrangement, option, exercise price range, shares exercisable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s share-based payment arrangement, option, exercise price range, shares exercisable?
- Immix Biopharma, Inc. (IMMX) reported share-based payment arrangement, option, exercise price range, shares exercisable of $3.44M in Q1 2026.
- How has Immix Biopharma, Inc.'s share-based payment arrangement, option, exercise price range, shares exercisable changed year-over-year?
- Immix Biopharma, Inc.'s share-based payment arrangement, option, exercise price range, shares exercisable increased by 30.7% year-over-year, from $2.63M to $3.44M.
- What is the long-term trend for Immix Biopharma, Inc.'s share-based payment arrangement, option, exercise price range, shares exercisable?
- Over 4 years (2021 to 2025), Immix Biopharma, Inc.'s share-based payment arrangement, option, exercise price range, shares exercisable has grown at a 60.2% compound annual growth rate (CAGR), from $484.42K to $3.19M.